Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$1.1M
Filings
48
Firms Hired
2
Active Period
2020–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: — · Firm income: $90,000
Matched citations: H.R. 4299
Foster Care Stabilization Act
2026 · third_quarter · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: $110,000 · Firm income: —
Matched citations: H.R. 4299
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: — · Firm income: $90,000
Matched citations: H.R. 4299
Foster Care Stabilization Act
2026 · second_quarter · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: $110,000 · Firm income: —
Matched citations: H.R. 4299
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: — · Firm income: $90,000
Matched citations: H.R. 4299
Foster Care Stabilization Act
2026 · first_quarter · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: $110,000 · Firm income: —
Matched citations: H.R. 4299
Foster Care Stabilization Act
2025 · fourth_quarter · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to virtual supervision of infusion drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F).
Client expense: $110,000 · Firm income: —
Matched citations: H.R. 4299
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to virtual supervision of infusion drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F)
Client expense: — · Firm income: $90,000
Matched citations: H.R. 4299
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the 2026 Medicare Physician Fee Schedule Proposed Rule (CMS-1832-P).
Client expense: — · Firm income: $90,000
Matched citations: H.R. 4299
Foster Care Stabilization Act
2025 · third_quarter · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the 2026 Medicare Physician Fee Schedule Proposed Rule (CMS-1832-P).
Client expense: $110,000 · Firm income: —
Matched citations: H.R. 4299
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: — · Firm income: $90,000
Matched citations: H.R. 4299
To amend the Child Abuse Prevention and Treatment Act with respect to infants born with and identified as being affected by substance use or withdrawal symptoms, Neonatal Abstinence Syndrome, or Fetal Alcohol Spectrum Disorder, and for other purposes.
2025 · second_quarter · Firm: THE MCMANUS GROUP
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: — · Firm income: $90,000
Matched citations: H.R. 879
Foster Care Stabilization Act
2025 · second_quarter · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: $100,000 · Firm income: —
Matched citations: H.R. 4299
To amend the Child Abuse Prevention and Treatment Act with respect to infants born with and identified as being affected by substance use or withdrawal symptoms, Neonatal Abstinence Syndrome, or Fetal Alcohol Spectrum Disorder, and for other purposes.
2025 · second_quarter · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: $100,000 · Firm income: —
Matched citations: H.R. 879
To amend the Child Abuse Prevention and Treatment Act with respect to infants born with and identified as being affected by substance use or withdrawal symptoms, Neonatal Abstinence Syndrome, or Fetal Alcohol Spectrum Disorder, and for other purposes.
2025 · first_quarter · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to reimbursement of Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 879
To amend the Child Abuse Prevention and Treatment Act with respect to infants born with and identified as being affected by substance use or withdrawal symptoms, Neonatal Abstinence Syndrome, or Fetal Alcohol Spectrum Disorder, and for other purposes.
2025 · first_quarter · Firm: THE MCMANUS GROUP
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 879
Invest in American Railroads Act
2024 · fourth_quarter · Firm: THE MCMANUS GROUP
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. 10545 the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act.
Client expense: — · Firm income: $80,000
Matched citations: HR 2474
To amend the Occupational Safety and Health Act of 1970 to prohibit emergency temporary standards with respect to vaccines, and for other purposes.
2024 · fourth_quarter · Firm: THE MCMANUS GROUP
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. 10545 the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act.
Client expense: — · Firm income: $80,000
Matched citations: HR 5391
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. 10545 the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act.
Client expense: — · Firm income: $80,000
Matched citations: S. 2764
Invest in American Railroads Act
2024 · fourth_quarter · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - The Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. l0545 - the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R. l 0445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act Access to Alzheimer's Disease therapies.
Client expense: $27,000 · Firm income: —
Matched citations: HR 2474
To amend the Occupational Safety and Health Act of 1970 to prohibit emergency temporary standards with respect to vaccines, and for other purposes.
2024 · fourth_quarter · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - The Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. l0545 - the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R. l 0445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act Access to Alzheimer's Disease therapies.
Client expense: $27,000 · Firm income: —
Matched citations: HR 5391
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
Client expense: $27,000 · Firm income: —
Matched citations: HR 2630
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
Client expense: $27,000 · Firm income: —
Matched citations: H.R. 3561
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
Client expense: $27,000 · Firm income: —
Matched citations: HR 830
New Parents Act of 2021
2024 · fourth_quarter · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - The Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. l0545 - the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R. l 0445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act Access to Alzheimer's Disease therapies.
Client expense: $27,000 · Firm income: —
Matched citations: S. 2764
Source: Senate LDA